ASLAN Pharmaceuticals to Present at H.C. Wainwright 23rd Annual Global Investment Conference

Rhea-AI Summary

ASLAN Pharmaceuticals (Nasdaq:ASLN), a biopharmaceutical company focused on immunology, announced that CEO Dr. Carl Firth will present at the H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021. The conference runs from September 13-15, 2021. An on-demand recording of Dr. Firth's presentation will be available on September 13 at 7:00 AM ET on ASLAN’s Investor Relations website. ASLAN is developing innovative treatments, including ASLAN004 for atopic dermatitis and ASLAN003 for autoimmune diseases.

MENLO PARK, Calif. and SINGAPORE, Sept. 09, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced Dr Carl Firth, CEO, is scheduled to give a company presentation at the H.C. Wainwright 23^rd Annual Global Investment Conference on 13 September, 2021. The conference will be held from September 13 to September 15, 2021.

An on demand recording of the presentation will be made available on 13 September at 7:00am ET in the Investor Relations section of ASLAN’s website at www.ir.aslanpharma.com and at the following link: https://journey.ct.events/view/1b10cdbc-a1e0-4f84-b475-753e1832a13a

Media and IR contacts

Emma Thompson Spurwing Communications Tel: +65 6206 7350 Email: ASLAN@spurwingcomms.com

Ashley R. Robinson LifeSci Advisors, LLC Tel: +1 (617) 430-7577 Email: arr@lifesciadvisors.com

About ASLAN Pharmaceuticals
ASLAN Pharmaceuticals (Nasdaq:ASLN) is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. ASLAN is currently evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease. ASLAN has a team in Menlo Park, California, and in Singapore. For additional information please visit www.aslanpharma.com or follow ASLAN on LinkedIn.

FAQ

What is the date and time of ASLAN Pharmaceuticals' CEO presentation at the H.C. Wainwright conference?

Dr. Carl Firth, CEO of ASLAN Pharmaceuticals, will present on September 13, 2021, at 7:00 AM ET.

Where can I watch the ASLAN Pharmaceuticals CEO presentation recording?

The presentation recording will be available on ASLAN’s Investor Relations website on September 13, 2021.

What are the key products ASLAN Pharmaceuticals is developing?

ASLAN is developing ASLAN004 for atopic dermatitis and ASLAN003 for autoimmune diseases.

When is the H.C. Wainwright 23rd Annual Global Investment Conference?

The conference is scheduled from September 13 to September 15, 2021.

What does ASLAN Pharmaceuticals focus on?

ASLAN Pharmaceuticals focuses on developing innovative treatments in the field of immunology.